1. Canada Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
Zentek Ltd.

Zentek Ltd.

ZEN.V
Zentek Ltd.CA flagToronto Stock Exchange Ventures
0.65
CAD
-0.02
- -
69.90MMarket Cap
Zentek Ltd.
ZEN.V
(Toronto Stock Exchange Ventures)

Recent

price

0.65

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.01
- -
- -
Revenue per Share
-0.07
-0.03
-0.06
-0.06
-0.05
-0.07
-0.05
-0.02
-0.04
-0.02
-0.05
-0.34
-0.14
-0.12
-0.1
- -
-0.09
Basic EPS, GAAP
-0.09
-0.04
-0.04
-0.04
-0.02
-0.03
-0.03
-0.02
-0.02
-0.02
-0.02
-0.13
-0.15
-0.08
-0.06
- -
-0.05
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-0.08
0.2
0.33
0.32
0.29
0.26
0.25
0.26
0.33
0.3
0.28
0.36
0.2
0.09
0.05
- -
0.01
Book Value per Share
0.39
0.26
0.4
0.39
0.36
0.36
0.37
0.35
0.37
0.33
0.33
0.45
0.31
0.2
0.14
- -
0.09
Tangible Book Value per Share
28
40
41
54
56
60
62
63
67
77
84
92
99
101
103
- -
105
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-3,528.46
-20,112.48
-40,174.8
-1,100.37
-5,981.22
-5,981.22
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
1
1
1
1
Depreciation Expense
-2
-1
-2
-4
-3
-4
-3
-2
-2
-2
-4
-32
-14
-12
-10
-10
-10
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-9,330.95
-19,784.87
-39,254.06
-1,150.68
-5,882.61
-5,882.61
Profit Margin (%)
8
3
6
2
- -
- -
1
- -
1
1
1
30
16
4
1
-1
-1
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
1
- -
2
2
LT Debt
11
10
16
21
20
21
23
22
25
26
27
42
30
20
15
10
10
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
-21.76
-22.82
-18.08
-26.58
-18.23
-9.86
-12.72
-6.8
-16.6
-111.94
-54.53
-80.6
-132.9
-291.29
-291.29
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
2
2
2
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
105
107
108
Market Capitalization
111
94
76

Working Capital

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
3
3
2
Cash, Cash Equivalents & STI
1
2
1
Accounts Receivable, Net
- -
- -
- -
Inventories
1
1
- -
Total Current Liabilities
3
3
4
Payables & Accruals
3
3
3
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-4.37%
-13.92%
-33.54%
Free Cash Flow
46.45%
84.47%
-19.3%
Net Income, GAAP
72.15%
125.8%
-2.71%
Sales/Revenue/Turnover
- -
- -
-80.97%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
1
1
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.03
-0.03
-0.03
- -
-0.12
2025
-0.03
-0.03
-0.02
- -
-0.1
2026
-0.01
-0.02
-0.02
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Visiomed Group S.A. (ALVMG.PA)
Shandong Weigao Group Medical Polymer Company Limited (SHWGY)
Straumann Holding AG (SAUHF)
Gerresheimer AG (GXI.SW)
PT Maja Agung Latexindo Tbk (SURI.JK)
Femasys Inc. (FEMY)
Business
Zentek Ltd. is a Canadian intellectual property development and commercialization company specializing in advanced nanomaterials, primarily graphene-based technologies. The company’s core products and services include graphene materials derived from its Albany graphite deposit; graphene-based antimicrobial coatings marketed under the ZenGUARD™ brand; surgical masks; HVAC filters enhanced with graphene-silver technology; personal protective equipment; rapid detection point-of-care diagnostic tests; pharmaceutical products based on graphene compounds; and research and development in graphene oxide synthesis and aptamers. Zentek operates through wholly owned subsidiaries, including Albany Graphite Corp., focusing on the purification and commercial exploitation of graphite, targeting markets in healthcare, biotechnology, and high-technology industrial sectors across Canada, the United States, the Middle East, India, and South America. Founded in 2008 and headquartered in Guelph, Ontario, Zentek has transitioned from mineral exploration to a technology commercialization focus emphasizing healthcare applications and advanced materials. Recent major developments include a strategic CEO transition with Mohammed Jiwan appointed as CEO in November 2025; the announcement of a novel Graphite Gel-Based Fire-Retardant product called GraphGel™, along with an exclusive U.S. licensing agreement with Altek Advanced Materials Inc. for commercial distribution in the U.S. market; expansion of ZenGUARD™ Enhanced Air Filters demonstrating significant infectious aerosol removal efficiency; and a non-exclusive licensing letter of intent with Altek for U.S. commercialization rights. Zentek’s Albany Graphite Corp. subsidiary achieved ultra-high purity graphite (5N, 99.9992%) meeting nuclear industry standards, supporting high-tech applications. The company also strengthened its global footprint through partnerships enabling production and marketing in Gulf Cooperation Council countries and secured funding and operational expansions focusing on commercialization of proprietary nanotechnologies within healthcare prevention, detection, and treatment segments.

Company News

APIChatGPT

  • feeds.newsfilecorp.com

    Zentek Ltée : Albany Graphite Corp. mandate AppEco pour une étude indépendante de recherche de marché et d'analyse économique